The apparently strong correlation between the price of eggs and biotech stocks is a neat illustration of why 2023 has been so frustrating for investors in the life sciences, where market swings seem as reliant on macroeconomic trends as on whether new drugs turn out to work.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,